v3.26.1
Consolidated Statements of Operations - USD ($)
 12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Revenue    
Total revenue $ 2,065,292 $ 3,008,361
Operating Expenses and Costs    
Practice salaries and benefits 1,016,543 1,995,127
Other practice operating expenses 973,048 1,556,759
Cost of product revenue 51,568 96,237
Selling, general and administrative expenses 2,035,516 3,038,936
Depreciation and amortization 101,871 282,950
Impairment loss 716,000
Total Operating Expenses and Costs 4,178,546 7,686,009
Loss from operations (2,113,254) (4,677,648)
Other Income (Expenses)    
Gain (loss) on extinguishment of debt 317,982 (178,986)
Gain (loss) on change in fair value of debt (618,208) 84,109
Gain on sale of assets 168,722
Gain on change in fair value of derivative financial instruments 8,644
Amortization of original issue discounts on notes payable (828,006) (1,316,165)
Gain from realization of contingent sale consideration receivable 125,355
Interest expense and other (216,134) (168,144)
Total other income (expenses) (1,167,000) (1,453,831)
Loss before provision for income taxes (3,280,254) (6,131,479)
Provision for income taxes
Net loss $ (3,280,254) $ (6,131,479)
Net loss per share, basic and diluted:    
Basic (in Dollars per share) $ (1.16) $ (2.18)
Fully diluted (in Dollars per share) $ (1.16) $ (2.18)
Weighted average number of common shares:    
Basic (in Shares) 2,835,764 2,815,441
Fully diluted (in Shares) 2,835,764 2,815,441
Patient service revenue, net    
Revenue    
Total revenue $ 2,002,548 $ 2,872,177
Subscription revenue    
Revenue    
Total revenue 22,623 32,425
Product revenue    
Revenue    
Total revenue $ 40,121 $ 103,759